首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Quantitative determination of fifteen basic pharmaceuticals in ante- and post-mortem whole blood by high pH mobile phase reversed phase ultra high performance liquid chromatography-tandem mass spectrometry
【24h】

Quantitative determination of fifteen basic pharmaceuticals in ante- and post-mortem whole blood by high pH mobile phase reversed phase ultra high performance liquid chromatography-tandem mass spectrometry

机译:高pH流动相反相超高效液相色谱-串联质谱法定量测定死前和死后全血中的15种基本药物

获取原文
获取原文并翻译 | 示例
       

摘要

An ultra high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method was developed and validated for the determination of fifteen basic pharmaceuticals, for analysis of post- and ante-mortem whole blood samples. The following compounds were included: amitriptyline and its metabolite nortriptyline, trimipramine, mianserin, mirtazapine, citalopram, paroxetine, sertraline, and venlafaxine (all antidepressants), levomepromazine and quetiapine (antipsychotics), ketobemidone and tramadol (analgesics), alimemazine (sedative antihistamine), and metoprolol (beta-blocker). The sample pretreatment consisted of liquid-liquid extraction (LLE) using ethylacetate:n-heptane (80:20, v/v). Six deuterated analogues were used as internal standards (IS). The compounds were separated using a reversed phase C18-column (2.1mm×100mm, 1.7μm), a flow rate of 0.5mL/min, and gradient elution with 5mM ammonium formate pH 10.2 and acetonitrile. Quantification was done by MS/MS using multiple reaction monitoring (MRM) in positive mode, using two transitions for the compounds and one transition for the IS. The run time of the method was 8min including equilibration time. The calibration curves had R2 values above 0.995 for all the compounds. The intermediate precision had a relative standard deviation (RSD, %) ranging between 2.0 and 16%. Recoveries of the compounds were ≥81%. The lower limits of quantifications (LLOQs) for the compounds varied from 5.0nmol/L to 0.10μmol/L (1.3-26ng/mL) and the limits of detections (LODs) from 1.0 to 20nmol/L (0.24-5.3ng/mL). LLOQ corresponds to 0.28-5.5pg injected on column. Matrix effects (ME) were between 91 and 113% when calculated against an IS. A comparison with former confirmation LC-MS methods at the Norwegian Institute of Public Health, Division of Forensic Medicine and Drug Abuse Research (NIPH) was performed during method validation. Good correlation was seen for all compounds except sertraline, where the old LC-MS method was showing 33% higher results. The method has been running on a routine basis for more than a year, and has proven to be very robust and reliable with results for external quality samples, including sertaline, corresponding well to consensus mean or median.
机译:开发了一种超高效液相色谱-串联质谱(UHPLC-MS / MS)方法,并已验证该方法可用于测定15种基本药物,并用于事后和事前全血样品分析。包括以下化合物:阿米替林及其代谢物去甲替林,曲米帕明,米安色林,米氮平,西酞普兰,帕罗西汀,舍曲林和文拉法辛(所有抗抑郁药),左美丙嗪和喹硫平(抗精神病药),酮美见酮和曲马多胺(肛门药)和美托洛尔(β受体阻滞剂)。样品预处理包括使用乙酸乙酯:正庚烷(80:20,v / v)的液-液萃取(LLE)。六个氘代类似物用作内标(IS)。使用反相C18柱(2.1mm×100mm,1.7μm),0.5mL / min的流速和5mM甲酸铵pH 10.2和乙腈进行梯度洗脱,分离化合物。使用正反应模式的多反应监测(MRM)通过MS / MS进行定量,其中化合物的两个过渡和IS的一个过渡。该方法的运行时间为8分钟(包括平衡时间)。所有化合物的校准曲线的R2值均高于0.995。中间精度的相对标准偏差(RSD,%)在2.0%至16%之间。化合物的回收率≥81%。化合物的定量下限(LLOQ)从5.0nmol / L到0.10μmol/ L(1.3-26ng / mL)不等,检测限(LOD)从1.0到20nmol / L(0.24-5.3ng / mL)不等)。 LLOQ对应于在色谱柱上注入的0.28-5.5pg。当根据IS计算时,基质效应(ME)在91%至113%之间。在方法验证期间,与挪威公共卫生研究所法医学和药物滥用研究部(NIPH)先前确认的LC-MS方法进行了比较。除舍曲林外,所有化合物均具有良好的相关性,而旧的LC-MS方法显示的结果高出33%。该方法已经常规运行了一年多,并且已被证明非常健壮和可靠,其外部质量样品的结果(包括舍曲林)非常符合共识平均值或中位数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号